Randomized study of saquinavir with ritonavir or nelfinavir together with delavirdine, adefovir, or both in human immunodeficiency virus-infected adults with virologic failure on indinavir: AIDS Clinical Trials Group study 359

Journal of Infectious Diseases

Volumn 182, Issue 5, 2000, Pages 1375-1384

  Gulick, Roy M ^a   Hu, X Joan ^b,l   Fiscus, Susan A ^c   Fletcher, Courtney V ^d   Haubrich, Richard ^e   Cheng, Hailong ^b   Acosta, Edward ^d,m   Lagakos, Stephen W ^b   Swanstrom, Ronald ^c   Freimuth, William ^g,n   Snyder, Sally ^h   Mills, Charlotte ^j   Fischl, Margaret ^k   Pettinelli, Carla ⁱ   Katzenstein, David ^f  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^g PFIZER INC   (United States)

^h SOCIAL AND SCIENTIFIC SYSTEMS INC   (United States)

ⁱ NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^j OHIO STATE UNIVERSITY   (United States)

^k UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^l UNIVERSITY OF MEMPHIS   (United States)

^m UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

ⁿ GLAXOSMITHKLINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR; DELAVIRDINE; NELFINAVIR; RITONAVIR; SAQUINAVIR; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT FAILURE; VIRUS LOAD;

ADENINE; ADULT; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; DELAVIRDINE; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HIV INFECTIONS; HUMANS; MALE; NELFINAVIR; PHOSPHONIC ACIDS; PROSPECTIVE STUDIES; RITONAVIR; RNA, VIRAL; SAQUINAVIR;

EID: 0033794231     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315867     Document Type: Article

References (33)

1. Antiretroviral therapy in adults: Updated recommendations of the International AIDS Society - USA panel
2. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy
3. Simultaneous vs sequential initiation of therapy with indinavir, zidovudine, and lamivudine for HIV-1 infection: 100 Week follow-up
4. Immunologic responses associated with 12 weeks of combination therapy consisting of zidovudine, lamivudine, and ritonavir: Results of AIDS Clinical Trials Group protocol 315
5. Ritonavir and saquinavir combination therapy for the treatment of HIV infection
6. Activity of the soft gelatin formulation of saquinavir in combination therapy in antiretroviral-naive patients
7. Treatment with amprenavir alone or amprenavir with zidovudine and lamivudine in adults with human immunodeficiency virus infection
8. Combination therapy containing ritonavir plus saquinavir has superior short-term antiretroviral efficacy: A randomized trial
9. Virological treatment failure of protease inhibitor therapy in an unselected cohort of HIV-infected patients
10. Clinical outcome and predictive factors of failure of highly active antiretroviral therapy in antiretroviral-experienced patients in advanced stages of HIV-1 infection
11. HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: Response to both initial and salvage therapy
12. Virological response to protease inhibitor therapy in an HIV clinic cohort
13. Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: A prospective cohort study
14. Outcome and predictors of failure of highly active antiretroviral therapy: One-year follow-up of a cohort of human immunodeficiency virus type 1-infected persons
15. Activity of a ritonavir plus saquinavir-containing regimen in patients with virologic evidence of indinavir or ritonavir failure
16. Treatment response and durability of a double protease inhibitor therapy with saquinavir and ritonavir in an observational cohort of HIV-1-infected individuals
17. The antiviral effect of ritonavir and saquinavir in combination amongst HIV-infected adults: Results from a community-based study
18. Interim analysis using repeated confidence bands
19. Virologic responses to a ritonavir-saquinavir-containing regimen in patients who had previously failed nelfinavir
20. The SPICE study: 48-Week activity of combinations of saquinavir soft gelatin and nelfinavir with and without nucleoside analogues: Study of protease inhibitor combinations in Europe
21. In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors
22. Genetic correlates of in vivo resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor
23. Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimens
24. Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy
25. Drug-resistance genotyping in HIV-1 therapy: The VIRADAPT randomised controlled trial
26. Efficacy and safety of adefovir dipivoxil with antiretroviral therapy
27. Competing drug-drug interactions among multidrug antiretroviral regimens used in the treatment of HIV-infected subjects